Depression and Anxiety in Adults With Hidradenitis Suppurativa

Abstract

Background: The literature surrounding the intersection of Hidradenitis Suppurativa (HS) and psychiatric comorbidities, particularly depression and anxiety, has garnered increasing attention in recent years. Literature Review: Further exploration by (O Perche et al., 2022) illustrates the social ramifications of HS, where patients often face isolation and impaired social functioning. The psychological toll of HS is compounded by social anxiety, which can exacerbate the challenges of social participation. This view is supported by the findings of (Agarwal et al., 2022), who systematically reviewed the symptomatology associated with HS and identified itch as a significant factor affecting patients' quality of life, thereby linking physical discomfort to emotional distress. The prevalence of depression and anxiety among HS patients is further corroborated by (E. Rymaszewska et al., 2022), who conducted a cross-sectional study in Poland, revealing a heightened risk of suicidality in this population. This aligns with the findings of (Ting Ooi et al., 2022), which emphasize the profound psychosocial burden of HS, particularly within the Singaporean context, highlighting how demographic factors may influence the patient experience. Lastly, (Ortiz-Álvarez et al., 2023) reinforced the established connection between HS and mental health issues by assessing suicide risk, advocating for a comprehensive approach to care that integrates both physical and psychological considerations. Conclusion: In conclusion, the cumulative evidence from these studies strongly advocates for a holistic treatment approach for HS patients, recognizing the intricate interplay between their physical symptoms and psychological health. This integrated perspective is essential for improving overall patient outcomes and addressing the significant mental health challenges faced by individuals with HS.